Partner Headlines - LLY

  1. AbbVie Beats, But Stock Falls; Lilly Cuts Guidance

    IBD
  2. UPDATE: Eli Lilly Posts Upbeat Q4 Profit, Sales Decline

    Benzinga
  3. Earnings Scheduled For January 30, 2015

    Benzinga
  4. 10 Must Watch Stocks for Today

    Benzinga
  5. Box Ready To Unwrap IPO In Hot Online Storage Field

    IBD
  6. Feeling Good With This Med Company

    GuruFocus
  7. Eli Lilly

    IBD
  8. Here Is Goldman Sachs' Potential Pair Trade For 2 Drug Giants

    Benzinga
  9. 10 Biotech Stories You Might've Missed This Week

    Benzinga
  10. Eli Lilly Has 'Turned The Corner,' Upgraded

    IBD
  11. Exclusive: JPMorgan Chase CEO Jamie Dimon Talks Cancer Recovery, ...

    FoxBusiness
  12. Eil Lilly CEO Talks New Product Launches, Pricing Pressure From ...

    Benzinga
  13. FDA Issues Import Block On Eli Lilly's Cialis

    Benzinga
  14. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  15. Deutsche Bank, Stifel Differ On Outlook For Eli Lilly

    Benzinga
  16. Benzinga's Top Upgrades

    Benzinga
  17. Jefferies Upgrades Eli Lilly To Buy

    Benzinga
  18. UPDATE: Deutsche Bank Downgrades Eli Lilly On Positive Outlook, ...

    Benzinga
  19. Eli Lilly

    IBD
  20. Alkermes Hits High On Schizophrenia Drug Results

    IBD
  21. Eli Lilly Moves Higher Following FY 2014 & 2015 Outlook

    Benzinga
  22. Benzinga's Top #PreMarket Losers

    Benzinga
  23. Fast Money Halftime Report Final Trade From January 6

    Benzinga
  24. US Stock Futures Surge Ahead Of Manufacturing Data

    Benzinga
  25. Roche Drugs For Alzheimer's, Breast Cancer Disappoint

    IBD
  26. 7 Stocks You Should Be Watching Today

    Benzinga
  27. Eli Lilly

    IBD
  28. Lilly Upgraded On 2 Potential Blockbuster Drugs

    IBD
  29. Alexandria Real Estate REIT Inks Rx For Pharma Boom

    IBD
  30. Biogen Alzheimer's Drug Succeeding In Early Tests

    IBD
  31. Zosano Pharma and Eli Lilly and Company Enter Into Exclusive ...

    Benzinga
  32. Sanofi's Bullish Pipeline Forecast Underwhelms Street

    IBD
  33. Screening Pharma Stocks Amid Turnaround

    YCharts
  34. Sarah Ketterer Dives in when Others Pull Out

    GuruFocus
  35. Credit Suisse Raises Eli Lilly Price Target

    Benzinga
  36. Veeva Systems Flies High On Cloud For Life Sciences

    IBD
  37. Sanofi Axes CEO, Hit By Multiple Downgrades

    IBD
  38. French Drugmaker Sanofi Warns Of Tougher Competition

    IBD
  39. US Stock Futures Rise Ahead Of Earnings, Economic Data

    Benzinga
  40. Earnings Scheduled For October 23, 2014

    Benzinga
  41. CANDA NK-2 Files Motion To Dismiss Patent Infringement Suit

    Benzinga
  42. Lilly, Zymeworks Announce Expansion Of Strategic Licensing And ...

    Benzinga
  43. Benzinga Weekly Preview: Earnings Season Is In Full Swing

    Benzinga
  44. Celgene, Alexion Among 4 IBD 50 Medical s To Report

    IBD
  45. UPDATE: Lilly To Initiate Efforts To Sell Guayama Site

    Benzinga
  46. Lilly Announces Plan to Realign Puerto Rico Manufacturing Operations

    Benzinga
  47. Drug Analysts Mull End Of 'Double Irish' Loophole

    IBD
  48. Pharma Stocks: Surprising Shift In U.S. Drug Market

    YCharts
  49. Meet 5 Top International Stocks Not Based In China

    IBD
  50. Dyax Offers Highlights of Recent Progress in Licensing, Funded-Research ...

    Benzinga
  51. Lipocine Inc Halted: Feds Eye Safety, Efficacy Of Testosterone

    Benzinga
  52. Drug giants target Alzheimer's

    IBD
  53. What Is A High Risk Market?

    Benzinga
  54. Higher Yielding Stocks With A Cheap EV/EBITDA Ratio And Low Debt ...

    GuruFocus
  55. Markets Little Changed In Low Volume And Slow News Ahead Of Long ...

    Benzinga
  56. Deutsche Bank: Eli Lilly At 'Critical Stage' In Its Journey

    Benzinga
  57. Deutsche Bank Starts Pfizer, Lilly at Buy, Merck, Bristol-Myers ...

    Benzinga
  58. New Type 2 Diabetes Treatment Jardiance Tablets For Adults Now ...

    Benzinga
  59. UPDATE: Tigress Initiates Coverage On Eli Lilly

    Benzinga
  60. Dow Suffers 300 Point Drop; S&P 500 And Nasdaq Also Tumble

    Benzinga
  61. Stocks Lower As Earnings Season Takes Back Seat To Geopolitical ...

    Benzinga
  62. Thursday Morning Earnings Reports

    Benzinga
  63. Earnings Scheduled For July 24, 2014

    Benzinga
  64. New Study Shows Beta-Amyloid Imaging Is Associated With Altered ...

    Benzinga
  65. Lilly And Immunocore Enter Immunotherapy Agreement To Co-Discover ...

    Benzinga
  66. Benzinga's Top #PreMarket Gainers

    Benzinga
  67. US Stock Futures Mostly Higher Ahead Of Goldman Sachs Earnings

    Benzinga
  68. Barclays Downgrades Pharmaceutical Sector

    Benzinga
  69. UPDATE: Barclays Upgrades Eli Lilly Despite Sector Downgrade

    Benzinga
  70. Benzinga's Top Upgrades

    Benzinga
  71. Eli Lilly is on the Right Track

    GuruFocus
  72. Celgene Sees Better Results For Psoriatic Arthritis

    IBD
  73. Eli Lilly Bets Big on Diabetes, Cancer Drugs

    FoxBusiness
  74. Novo Nordisk Raises Insulin Prices As Demand Grows

    IBD
  75. ASCO Meeting Day 3: Do More Treatments Equal A Longer Life?

    Benzinga
  76. ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica ...

    Benzinga
  77. John Paulson's 4 Stocks Trading for Less Than He Paid for Them

    GuruFocus
  78. Lilly Says Abemaciclib in Phase 1 Study Demonstrated Single-Agent ...

    Benzinga
  79. Eli Lilly insulin trial succeeds

    IBD
  80. Cross-Border Megamergers Drive Global Takeover Boom

    IBD
  81. Google Celebrates Dorothy Hodgkin & Her Contributions To Chemistry

    Benzinga
  82. Eli Lilly's Basal Insulin Outperforms Lantus In Trial

    IBD
  83. UPDATE: Eli Lilly Announces Peglispro Shows Superiority Compared ...

    Benzinga
  84. Can Pfizer Make Up Its Loss?

    GuruFocus
  85. Merck Sells Consumer Unit To Bayer To Focus On R&D

    IBD
  86. Bayer Buys Merck Consumer Care Unit

    FoxBusiness
  87. Will Pfizer's Q1 2014 Earnings Beat the Street on May 5, 2014?

    GuruFocus
  88. AstraZeneca Rejects Pfizer's $106B Buyout Bid

    FoxBusiness
  89. Novo Nordisk Struggles In U.S. Market; Q1 Sales Miss

    IBD
  90. Novo Nordisk Q1 Revenue Misses; Guidance Lowered

    IBD
  91. Vanguard Health Care Fund's Top Quarterly Holdings

    GuruFocus
  92. Actavis Earns Over-The-Top Q1

    IBD
  93. Actavis Beats Q1 Views, Looks To Supersized Future

    IBD
  94. Actavis Q1 Earnings Beat On Generic Cymbalta Surprise

    IBD
  95. China Rule Change Further Opens Yuan To World Markets

    IBD
  96. These Three Pharmaceutical Companies Shake The Market With Their ...

    GuruFocus
  97. Drugmakers' Q1 was anemic

    IBD
  98. Eli Lilly Jr. Made His Firm A Pharmaceutical Power

    IBD
  99. Earnings Scheduled For April 24, 2014

    Benzinga
  100. Big Pharmas Swap Specialties

    IBD
Trading Center